Health Care & Life Sciences » Pharmaceuticals | Granules India Ltd.

Granules India Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
10,839
12,917
13,572
14,106
16,846
22,792
Cost of Goods Sold (COGS) incl. D&A
8,312
9,959
9,873
9,929
12,569
15,709
Gross Income
2,527
2,958
3,699
4,176
4,277
7,083
SG&A Expense
1,194
1,342
1,437
1,721
2,135
4,298
EBIT
1,288
-
-
-
2,042
2,786
Unusual Expense
14
-
-
-
-
-
Non Operating Income/Expense
14
11
8
30
58
267
Interest Expense
204
323
371
323
331
285
Pretax Income
1,124
1,280
1,860
2,050
1,800
3,255
Income Tax
371
371
611
652
634
891
Equity in Affiliates
-
-
19
247
160
-
Consolidated Net Income
752
909
1,230
1,645
1,326
2,364
Net Income
752
909
1,230
1,645
1,326
2,364
Net Income After Extraordinaries
752
909
1,230
1,645
1,326
2,364
Net Income Available to Common
752
909
1,230
1,645
1,326
2,364
EPS (Basic)
3.72
4.46
5.95
7.52
5.49
9.30
Basic Shares Outstanding
202
204
207
219
242
-
EPS (Diluted)
3.65
4.41
5.83
7.48
5.47
-
Diluted Shares Outstanding
206
206
211
220
242
-
EBITDA
1,598
2,104
2,775
3,073
2,804
3,840
Other Operating Expense
45
40
71
97
100
-
Non-Operating Interest Income
12
15
48
44
31
-

About Granules India

View Profile
Address
2nd Floor, 3rd Block
Hyderabad TS 500081
India
Employees -
Website http://www.granulesindia.com
Updated 07/08/2019
Granules India Ltd. engages in the manufacturing and marketing of pharmaceutical products. It offers active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. The company was founded by Krishna Prasad Chigurupati on March 18, 1991 and is headquartered in Hyderabad, India.